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ABSTRACT CD81 is a member of the tetraspanin family that has been described to have a 
key role in cell migration of tumor and immune cells. To unravel the mechanisms of CD81-
regulated cell migration, we performed proteomic analyses that revealed an interaction of 
the tetraspanin C-terminal domain with the small GTPase Rac. Direct interaction was con-
firmed biochemically. Moreover, microscopy cross-correlation analysis demonstrated the in 
situ integration of both molecules into the same molecular complex. Pull-down experiments 
revealed that CD81-Rac interaction was direct and independent of Rac activation status. 
Knockdown of CD81 resulted in enhanced protrusion rate, altered focal adhesion formation, 
and decreased cell migration, correlating with increased active Rac. Reexpression of wild-
type CD81, but not its truncated form lacking the C-terminal cytoplasmic domain, rescued 
these effects. The phenotype of CD81 knockdown cells was mimicked by treatment with a 
soluble peptide with the C-terminal sequence of the tetraspanin. Our data show that the 
interaction of Rac with the C-terminal cytoplasmic domain of CD81 is a novel regulatory 
mechanism of the GTPase activity turnover. Furthermore, they provide a novel mechanism 
for tetraspanin-dependent regulation of cell motility and open new avenues for tetraspanin-
targeted reagents by the use of cell-permeable peptides.
INTRODUCTION
Tetraspanins are involved in adhesion and migration processes, such 
as leukocyte extravasation and cancer invasion (Yáñez-Mó et al., 
2001a, 2001b, 2009; Hemler, 2003; Tarrant et al., 2003; Barreiro 
et al., 2005; Charrin et al., 2009), and are promising targets for can-
cer therapeutics (Sala-Valdes et al., 2012).
Multiple studies have provided evidence that tetraspanins regu-
late cell migration. Initial reports used antitetraspanin antibodies 
(Lagaudriere-Gesbert et al., 1997; Yáñez-Mó et al., 1998): anti-CD81 
antibodies inhibited α6β1-induced migration (Domanico et al., 
1997), and anti-CD151 and anti-CD81 antibodies reduced migra-
tion of endothelial or epithelial cells (Yáñez-Mó et al., 1998; Penas 
et al., 2000). More recently, anti-CD81 antibodies were found to 
ameliorate autoimmune encephalomyelitis by blocking monocyte 
transmigration (Dijkstra et al., 2008).
Genetic studies also support this role for tetraspanins. Small in-
terfering RNA (siRNA)-mediated deletion of CD9 and CD151 en-
hanced primary melanocyte motility (Garcia-Lopez et al., 2005), 
whereas targeting of CD151 enhanced melanoma cell migration 
(Hong et al., 2006). CD82 overexpression suppressed the migration 
of oligodendrocyte precursors (Mela and Goldman, 2009). In the 
immune system, CD81 regulates the migration and trafficking of 
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integrin’s avidity for ligands and regulates 
outside-in signaling (Berditchevski and 
Odintsova, 1999), including the activation of 
FAK, Src, p130cas and paxillin (Yamada et al., 
2008), protein kinase B, endothelial nitric-
oxide synthase, and the small GTPases Rac1 
and Cdc42 (Takeda et al., 2007).
Emerging evidence suggests that tetras-
panins also interact with different cytoplas-
mic molecules, facilitating the activation of 
signaling cascades. At least five tetraspan-
ins—CD9, CD63, CD81, CD151, and A15/
TALLA/Tspan7—associate with type II phos-
phatidylinositol 4-kinase (Berditchevski et al., 
1997; Yauch and Hemler, 2000). Tetraspanin 
association to PI4K may play a role in cell 
migration (Mazzocca et al., 2008), bacterial 
infection (Tham et al., 2010), and tumor cell 
proliferation (Carloni et al., 2004). When ac-
tivated, protein kinase C (PKC) associates 
with CD9, CD53, CD81, CD82, and CD151 
(Zhang et al., 2001a), and PKC-mediated 
phosphorylation was shown to be neces-
sary for α3-integrin−dependent signaling 
to FAK, p130cas, and paxillin during spread-
ing and migration (Zhang et al., 2001b). 
The C-terminal cytoplasmic domain of 
CD63 binds to the adaptor protein syn-
tenin-1 (Latysheva et al., 2006) and that of 
CD81 to 14-3-3 proteins (Clark et al., 2004). 
Tetraspanins connect to the actin cytoskel-
eton through ezrin, radixin, and moesin 
(ERM) proteins (Sala-Valdes et al., 2006), 
and tetraspanin-mediated signaling may 
control actin polymerization and remodel-
ing. However, the precise mechanisms 
through which tetraspanins control cell mi-
gration remain largely unexplored.
In this study, we performed pull-down as-
says using the cytoplasmic C-terminus tail of 
CD81 as bait, followed by high-throughput 
protein identification by mass spectrometry, 
to identify new intracellular interacting part-
ners of tetraspanins implicated in the regula-
tion of actin dynamics and cell migration. We 
found that tetraspanin CD81 associates with 
the small GTPase Rac. We also demonstrate 
that CD81 interaction with Rac limits the 
GTPase activation within the plasma mem-
brane, providing an unexpected novel regu-
latory mechanism of Rac activity turnover.
RESULTS
CD81 associates with Rac1 through its cytoplasmic 
C-terminal region
Searching for novel interactions of CD81 implicated in cell migra-
tion, we performed mass spectrometry using pull downs of T-
lymphoblast cell lysates with biotinylated peptides corresponding 
to the C-terminal cytoplasmic region of CD81 as bait. The analysis 
identified two peptides belonging to the GTPase Rac1 and five cor-
responding to Rac2 (Figure 1A) in the bound fraction. The associa-
tion of CD81 with Rac was also detected by pull-down assays with 
natural killer (Kramer et al., 2009) and dendritic (Nattermann et al., 
2006) cells, while CD9/CD81 double-knockout mice show defects in 
macrophage cell motility (Takeda et al., 2008).
Tetraspanins are highly hydrophobic proteins that cross the cel-
lular membrane four times, displaying N-terminal and C-terminal 
cytoplasmic domains. Tetraspanins structure tetraspanin-enriched 
microdomains (TEMs) at the plasma membrane that organize trans-
membrane proteins, including integrins, immunoglobulin-like adhe-
sion molecules and metalloproteinases, and signaling effectors 
(Yáñez-Mó et al., 2009, 2011). Integrin insertion in TEMs enhances 
FIGURE 1: The C-terminal domain of CD81 associates with the GTPase Rac1. (A) Primary 
T-lymphoblast lysates were incubated with biotinylated peptides of the C-terminal cytoplasmic 
domain of CD81. Pull downs were digested, and the resulting peptides were identified by 
high-throughput MS. (A) Representative MS/MS spectrum of a Rac2 peptide. (B) Rac 
immunoblot of HEK lysates pulled down with biotinylated peptides corresponding to C-terminal 
domains of tetraspanins CD9, CD81, CD82, and CD151, and tetraspanin-associated receptor 
EWI-2. Sepharose-negative control and total cell lysates are also shown. (C) Rac1-GST protein 
produced in E. coli was incubated with CD9 or CD81 C-terminal biotinylated peptides. GST 
binding was quantified by chemiluminescence. Data correspond to five independent 
experiments (mean ± SEM) *, p < 0.05 in one-way ANOVA. (D) Lysates from SUM159 (left) and 
HUVEC (right), either serum-starved (SF) and exposed to EGF (100 ng/ml) for 5 min (EGF) or 
maintained in standard serum culture conditions (S) were immunoprecipitated with anti-CD81 
(5A6) or and anti-CD9 (VJ1/20). Membranes were immunoblotted for Rac, CD81, and anti-CD9.
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peptides corresponding to the cytoplasmic 
sequence of other tetraspanin-associated 
membrane molecules (EWI-2, ICAM-1, 
VCAM-1) and other membrane receptors 
(CD147, CD69, CXCR4, CCR7) were unable 
to pull down Rac (Figure 1B; unpublished 
data). Direct interaction with the C-terminal 
sequence of CD81 was confirmed by direct 
binding of Rac1–glutathione S-transferase 
(GST) protein obtained in Escherichia coli 
cultures (Figure 1C). Interaction between 
the endogenous molecules was confirmed 
by coimmunoprecipitation in serum-starved, 
serum-induced, or epidermal growth factor 
(EGF)-stimulated primary human umbilical 
vein endothelial cells (HUVEC) or SUM159 
breast carcinoma cells (Figure 1D).
CD81-Rac molecular complexes were 
detected in situ by total internal reflection 
microscopy (TIRFM)-based fluorescence im-
age cross-correlation analysis of mCherry-
CD81 and green fluorescent protein (GFP)-
tagged wild-type Rac (WT-Rac1; Figure 2A). 
Correlation studies rely on the analysis of 
fluorescence intensity fluctuations from fluo-
rescently tagged molecules in an image 
time series. The fluctuations, in this case, 
likely arise from diffusion and/or membrane 
binding–unbinding kinetics. The decay of 
the autocorrelation function for CD81 and 
wild type Rac (WT-Rac1) indicates that both 
molecules are producing fluorescence fluc-
tuations over the timescale of the measure-
ment (Figure 2B, top panels). This observa-
tion is typical for transmembrane receptors 
such as CD81, which diffuse in the cell mem-
brane on the seconds timescale (faster than 
cytosolic proteins), or proteins with slow ex-
change with the membrane, and suggests 
that we are measuring a Rac population that 
is either diffusing in the membrane or ex-
changing with a membrane-bound complex 
(Moissoglu et al., 2006).
As we have previously demonstrated, 
correlation analysis can also be applied to 
detect molecular complexes (Choi et al., 
2011). If two molecules tagged with differ-
ent fluorophores (e.g., GFP and mCherry) 
reside within the same molecular complex, 
they will produce similar temporal fluores-
cence intensity fluctuation patterns, which 
will be revealed by calculating the cross-
correlation function (see Materials and 
Methods; Wiseman et al., 2004; Brown 
et al., 2006; Digman et al., 2009). In the ab-
sence of a complex, the intensity fluctua-
tions are independent, and the cross-corre-
lation function will be featureless and 
indistinguishable from the noise level. The 
cross-correlation function of CD81 and WT-Rac-1 therefore confirms 
that the membrane-targeted Rac1 resides with CD81 in the same 
complex. CD81 also showed high cross-correlation with V12-Rac, a 
adherent cells (Figure 1B). Interestingly, the C-terminal cytoplasmic 
regions of the tetraspanins CD9, CD151, and CD82 did not associ-
ate with Rac (Figure 1B; unpublished data). Similarly, biotinylated 
FIGURE 2: CD81 and Rac are found in common molecular complexes. (A) Cross-correlation 
analysis of TIRFM time-lapse imaging of mCherry-CD81 and GFP-Rac in U2OS cells plated on 
2 μg/ml fibronectin. Time series consisted of 100 frames captured at 4-s intervals. A square 
region (∼ 80 μm2) in the image time series was selected for analysis (highlighted in the example 
shown). The average intensity of the analyzed regions for both channels showed minimal 
photobleaching or mechanical drift effects. Scale bars: 10 μm. (B) The auto- and cross-
correlation functions are presented on a semilogarithmic scale.
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suggesting a faster exchange of the GTPase 
with the membrane. Moreover, both mole-
cules showed no detectable cross-correla-
tion, further indicating that Rac specifically 
binds to the CD81 C-terminal region (Figure 
2B, bottom panels).
CD81 colocalizes with Rac1 and 
localizes anterior to nascent adhesions 
at the leading edge of migrating cells
We next studied the subcellular localization 
of CD81/Rac complexes in live cells. Stimu-
lation of SUM159 cells or HUVEC with EGF 
induced partial colocalization of endoge-
nous Rac and CD81 at the cell edge (Figure 
3, A and B), and similar results were observed 
during cell spreading (unpublished data). 
Colocalization at the leading lamella was not 
observed for tetraspanin CD151, which con-
centrated at cell–cell contacts, or for the gly-
cophosphatidylinositol (GPI)-linked receptor 
CD59 (Figure 3A). Analysis of similar samples 
using TIRFM, illuminating only ∼100 nm of 
the ventral surface of the cell, revealed the 
colocalization of CD81 and Rac1 at the 
edges of HUVEC cells (Figure 3C).
Loading of Rac with GTP is normally 
concomitant with its translocation to the 
plasma membrane. To determine whether 
association of CD81 with Rac depends on 
the activation state of the GTPase, we 
loaded SUM159 cell lysates with an excess 
of GDP or the nonhydrolyzable GTP ana-
logue GTP-γS. CD81-biotinylated pep-
tides pulled down similar amounts of Rac 
regardless of the GTP or GDP load, sug-
gesting that CD81 association with Rac is 
independent of the Rac activation state 
(Figure 4A).
The dynamic behavior of the CD81/Rac 
complexes in migrating cells was analyzed 
with a Förster resonance energy transfer 
(FRET)-based Raichu-Rac plasmid that 
allows the dynamic visualization of Rac 
activity (Ouyang et al., 2008). In human 
microvascular endothelial cells cotrans-
fected with DsRed-CD81 and Raichu-Rac, 
EGF stimulation induced a clear colocal-
ization of Rac activity with CD81 at the 
leading edges of the cells (Figure 4B and 
Supplemental Video S1). In resting cells, 
FRET signal was almost undetectable. To 
define more precisely the location of 
CD81-Rac complexes at the leading la-
mella, we cotransfected cells with AqGFP-
CD81 and orange-paxillin and monitored 
them using time-lapse TIRFM. CD81 con-
centrated at the edges of the cells (Figure 
4C, arrowhead, and Video S2), ahead of 
the nascent adhesions marked by paxillin (Figure 4C, arrow) sug-
gesting that CD81 may prime these foremost areas for Rac 
activation.
constitutively active mutant of Rac (Figure 2B, middle panels). 
Coexpression of WT-Rac with a CD81 mutant lacking the cytoplas-
mic region (CD81-ΔCyt) resulted in reduced Rac autocorrelation, 
FIGURE 3: Endogenous CD81 colocalizes with Rac. (A) SUM159 cells were fixed after 5 min of 
EGF stimulation (100 ng/ml), permeabilized, and costained for Rac1 and CD81, CD151, or CD59. 
A confocal plane of both channels is shown together with the merged image and an image 
overlaid with the colocalization mask in white. Scale bar: 20 μm. (B and C) HUVEC cells were 
plated onto 10 μg/ml of fibronectin for 30 min, fixed, permeabilized, and stained for Rac and 
CD81. Samples were analyzed by (B) confocal microscopy (maximal projection) or (C) TIRFM. 
Scale bar: (B) 10 μm; (C) 7.5 μm.
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cells and CD81-depleted cells (Figure 5C). 
Rac concentrated at the leading edge in 
both conditions, suggesting that CD81 is not 
required for Rac translocation to the plasma 
membrane (Figure 5C and Video S3).
Interestingly, active (GTP-bound) Rac 
levels, as detected by pull down with GST-
PAK-CRIB, were significantly higher in un-
stimulated CD81-silenced cells (p < 0.05 in 
Student’s t test). Moreover, in CD81-silenced 
cells, Rac-GTP levels remained largely unaf-
fected by EGF stimulation. Indeed, Rac ac-
tivity remained high and almost constant, 
being also significantly higher at 30 min of 
EGF stimulation compared with control cells 
(p < 0.05 in Student’s t test). In contrast, no 
significant differences were observed in 
RhoA activity (detected with GST-C21), 
which was only slightly reduced in CD81-si-
lenced cells (Figure 5D).
Cell protrusion during spreading de-
pends mainly on Rac-induced actin poly-
merization (Choi et al., 2008). Consistent 
with the higher levels of activated Rac, 
CD81-deficient cells displayed a faster rate 
of protrusion and spreading than control 
cells (Figure 6, A and B). Importantly, this ef-
fect was rescued using full-length CD81 but 
not with the C-terminus truncated form 
(CD81-ΔCyt) fused to GFP. Moreover, over-
expression of WT-CD81 had the opposite 
effect, slowing cell protrusion (Figure 6A).
The effects of CD81 depletion in actin 
polymerization and adhesion formation 
were visualized by staining F-actin and the 
adhesion protein paxillin in control and 
CD81-deficient cells. To normalize cell mor-
phology, we used micropatterned substrates 
(Thery et al., 2006) that permit averaging 
the staining of multiple cells with the same 
morphology, as well as analyzing the re-
sponse to geometric cues (Tan et al., 2004; 
Figure 6C). CD81-depleted cells showed in-
creased paxillin staining of focal adhesions 
(Figure 6C). Interestingly, adhesions in con-
trol cells were restricted to the rim of the la-
mellar edge, but formed in a broader region 
in CD81-silenced cells. CD81 depletion also 
induced a defective cell polarization in both 
F-actin and focal adhesions in polarizing mi-
cropatterns. CD81 silencing in primary 
HUVECs plated onto fibronectin also increased the size of focal ad-
hesions (Figure 6D), an effect reverted by cotransfection with full-
length CD81, but not with CD81-ΔCyt-GFP. It has been reported 
that protrusion rate presents a direct correlation with adhesion as-
sembly rate (Choi et al., 2008). We analyzed adhesion assembly and 
disassembly rates in cells interfered for CD81, with or without recon-
stitution of the expression with a complete or truncated CD81 form. 
For adhesion assembly rate, results were consistent with protrusion 
rates: silencing of CD81 accelerated adhesion assembly compared 
with control cells, and this phenotype was rescued by complete 
CD81 but not by the truncated form (Figure 6E). In contrast, no 
CD81 controls Rac activation dynamics during 
cell adhesion and migration
The functional significance of the CD81/Rac interaction was ex-
plored in cells with reduced endogenous CD81 expression by trans-
fection of two different siRNA sequences: one against the coding 
sequence and one against the 3′ untranslated region (3′UTR; see 
Material and Methods). After 48 h of siRNA transfection, down-
regulation was assessed by flow cytometry and Western blotting 
(Figure 5, A and B); experiments were performed only when down-
regulation was higher than 50%. We monitored the subcellular loca-
tion of GFP-coupled Rac1 during migration on fibronectin in control 
FIGURE 4: CD81 colocalizes with Rac activity anterior to nascent adhesions at the leading 
edge of migrating cells. (A) SUM159 cell lysates were loaded with 50 nM of GTP-γS or GDP 
before pull down with CD81 and CD9 C-terminal domain biotinylated peptides. GTP-γS/GDP 
Rac loading was assessed by pull down with GST-PAK-CRIB. (B) HMEC-1 cells were 
cotransfected with DsRed-CD81 and ECFP/Ypet Raichu-Rac. FRET signal for Raichu-Rac (left) 
and CD81 (right) are shown for untreated cells or cells stimulated with EGF (100 ng/ml). Scale 
bars: 10 μm. (C) HMEC-1 cells were cotransfected with Aq-GFP-CD81 and mOrange-paxillin and 
observed using TIRFM. Representative time points are shown. Arrowhead points to CD81 signal 
at the leading edge, while the arrow highlights the position of the nascent adhesions containing 
paxillin. Scale bars: 7.5 μm (top), 5 μm (bottom).
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tion, 100% of the cells were fluorescently labeled. The mean fluores-
cence intensity of the cells increased up to 3 h and declined thereaf-
ter, although 100% of the cells retained detectable fluorescence after 
24 h (Figure 7A; unpublished data). Both peptides faintly labeled the 
plasma membrane and strongly accumulated at intracellular vesicles 
(Figure 7B). Incubation with the CD81 C-terminal peptide, but not 
with the control, increased the basal levels of Rac activity, but pre-
vented its activation in response to EGF (Figure 7C), similar to what 
was observed when silencing CD81 in these cells. In the same man-
ner, CD81 C-terminal peptides induced a higher protrusion rate 
statistically significant differences were found between any of the 
groups for the rate of adhesion disassembly, indicating CD81 is able 
to modify the turnover of focal adhesions, exerting an effect on the 
assembly of the adhesions, but not on the disassembly.
To directly corroborate that CD81 regulated Rac activation by 
their interaction through the C-terminal cytosolic domain of the tet-
raspanin, we incubated cells with a fluorescently labeled, cell-perme-
able peptide corresponding to the C-terminal sequence of CD81 or 
with a scrambled combination of the same eight amino acids as a 
control. These peptides were readily internalized; at 1 h after incuba-
FIGURE 5: CD81 silencing does not impair Rac translocation to cell membrane but increases Rac activation. (A) Flow 
cytometry analyses of CD81 silencing. SUM159 cells were transfected with negative oligo or CD81 siRNA (b sequence) 
and stained for CD81 (left). Negative control, cells stained with the secondary antibody only (filled histogram) are shown 
for reference. For rescue experiments (right), cells were cotransfected with negative oligonucleotide (thick black line) or 
CD81c sequence siRNA and plasmid DNA encoding GFP (thin gray line), GFP-CD81 (gray dotted line), or truncated 
mutant CD81-ΔCyt-GFP (gray dashed line). (B) Western blot analyses of CD81 silencing. SUM159 cells were transfected 
with negative oligo or CD81 siRNA, and total cell lysates were blotted for CD81 content. α-Tubulin is shown as loading 
control. (C) SUM159 cells were cotransfected with negative oligonucleotide or CD81siRNA together with GFP-wild-
type-Rac1. Time-lapse images were acquired using wide-field fluorescence video microscopy. Maximal projections of 
representative time points are shown. Arrows point to Rac accumulation at the lamella of the migrating cells. Scale bars: 
10 μm. (D) SUM159 cells were transfected with negative oligonucleotide or CD81 siRNA, serum-starved, and stimulated 
with EGF (100 ng/ml) at the indicated times. Rac and Rho activation were analyzed by pull-down assays with GST-PAK-
CRIB or GST-C21, respectively. Blots are representative from at least three independent experiments.
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(Figure 7D) and increased the cell area after 
spreading (Figure 7E).
Therefore our data suggest that pertur-
bation of the Rac-CD81 interaction alters 
the normal Rac activation/inactivation cycle, 
resulting in increased but delocalized pro-
trusion and increased adhesion formation. 
Time-lapse video microscopy experiments 
revealed that these alterations in Rac activity 
by CD81 depletion decreased the rate of 
cell migration, an effect avoided by cotrans-
fection with full-length CD81 but not with 
the CD81ΔCyt mutant (Figure 8, A and B). 
Again, overexpression of WT-CD81 had the 
opposite effect, facilitating cell migration 
(Figure 8C), while treatment of cells with the 
permeable peptides recapitulated the phe-
notype of CD81 siRNA depletion, slowing 
cell motility (Figure 8D).
In sum, the binding of Rac to the C-termi-
nal cytoplasmic domain of CD81 is an im-
portant mechanism responsible for tetraspa-
nin regulation of cell migration. Furthermore, 
insertion into TEM emerges as a novel regu-
latory mechanism for Rac activity turnover.
DISCUSSION
Tetraspanins have been implicated in the 
regulation of cell migration in different bio-
logical scenarios. The current view favors an 
interpretation of these results based on the 
interaction of tetraspanins with other mem-
brane molecules in tetraspanin-enriched mi-
crodomains (Berditchevski, 2001; Yáñez-Mó 
et al., 2009). Our study provides the first evi-
dence that CD81 and Rac associate in the 
same multimolecular complex and empha-
sizes the role of tetraspanins as direct regu-
lators of signals that control cell migration.
Our results show that CD81 directly 
binds to Rac proteins. Mass spectrometry 
FIGURE 6: CD81 down-regulation increases protrusion rate and focal adhesion formation. 
(A) SUM159 cells were transfected with negative oligonucleotide or CD81 siRNA, together with 
GFP, GFP-CD81, or the GFP-tagged truncated C-terminal deletion form of CD81. In parallel 
experiments, cells were transfected with GFP or GFP-CD81. Protrusion rate (μm/s) was analyzed 
in TIRF time-lapse sequences of cells spreading on 10 μg/ml fibronectin. Data represent 
kymographs from three independent experiments (mean ± SEM). *, p < 0.05; **, p < 0.01; and 
***, p < 0.001 in one-way ANOVA (silencing and rescue experiments); *, p < 0.05 in Student’s t 
test for overexpression experiments. (B) Examples of cell spreading measured in (A). Binary 
images show the total area of spreading at 5 min, while the linear outline corresponds to the cell 
perimeter at time 0. Scale bar: 10 μm. (C) SUM159 cells were transfected with negative 
oligonucleotide or CD81 siRNA and seeded onto micropatterned slides. After 3 h of adhesion, 
samples were fixed, permeabilized, and stained for paxillin or F-actin. Images displayed are the 
average projections, in pseudocolor intensity scale, of more than 20 cells acquired in a wide-field 
fluorescence microscope. Scale bar: 10 μm. 
(D) Primary HUVECs were transfected with 
negative oligonucleotide or CD81 siRNA, 
together with GFP, GFP-CD81, or the GFP- 
tagged truncated C-terminal deletion form of 
CD81, and seeded on 2 μg/ml of fibronectin. 
Cells were stained for paxillin, and the area of 
focal adhesions (μm2) was quantified. Data 
are means ± SEM of measurements from 
three independent experiments. *, p < 0.05 
in one-way ANOVA. (E) Cells were 
transfected with mOrange-paxillin together 
with negative oligonucleotide or CD81 siRNA 
and GFP, GFP-CD81, or the GFP-tagged 
truncated C-terminal deletion form of CD81, 
then allowed to spread on 10 μg/ml 
fibronectin, and adhesion assembly and 
disassembly (depicted by paxillin) were 
analyzed in TIRFM time-lapse sequences. 
Data are means ± SEM of measurements 
from three independent experiments. 
**, p < 0.01 in one-way ANOVA.
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FIGURE 7: A cell-permeable peptide with CD81 C-terminal sequence affects Rac activity. (A) SUM159 cells were 
incubated with 1 μM of a fluorescently labeled cell-permeable peptide with the sequence of the C-terminal cytoplasmic 
domain of CD81 or a scrambled version for the indicated times. Cells were trypsinized and incorporation of the peptide 
analyzed by flow cytometry. (B) SUM159 cells were incubated for 2 h with 1 μM of the permeable peptides containing 
the sequence of the C-terminal cytoplasmic domain of CD81 or the scrambled version, fixed, and visualized by confocal 
microscopy. A maximal projection of the confocal stacks together with a phase-contrast image is shown. Scale bars: 
7.5 μm. (C) SUM159 cells were serum-starved, incubated for 2 h with 1 μM of the permeable peptides containing the 
sequence of the C-terminal cytoplasmic domain of CD81 or the scrambled version, and stimulated with EGF (100 ng/ml) 
at the indicated times. Rac activation was analyzed by pull-down assays with GST-PAK-CRIB. (D) SUM159 cells were 
incubated for 2 h with 1 μM of the permeable peptides containing the sequence of the C-terminal cytoplasmic domain 
of CD81 or the scrambled version. Protrusion rate (μm/s) was analyzed in TIRFM time-lapse sequences in cells spreading 
on 10 μg/ml fibronectin. Data represent kymographs from three independent experiments (mean ± SEM). **, p < 0.01 in 
Student’s t test. (E) SUM159 cells were incubated for 2 h with 1 μM of the permeable peptides containing the sequence 
of the C-terminal cytoplasmic domain of CD81 or the scrambled version, trypsinized, and plated onto 10 μg/ml 
fibronectin; fixed at indicated times; and stained for F-actin. Data represent the cell average area ± SEM from three 
independent experiments. *, p < 0.05, **, p < 0.01 in Student’s t test.
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analyses of CD81 pull downs show a preference for Rac2, which is 
enriched in T-lymphoblasts, over Rac1 (Guo et al., 2008). These re-
sults were corroborated in adherent cells with Rac-1 and by in vitro 
direct binding of Rac-1 protein produced in bacterial lysates to the 
C-terminal sequence of CD81. Previous data showed that interac-
tion of tetraspanin CD9 with α2β1-integrin interferes with mem-
brane anchorage of Rac (Cailleteau et al., 2010), while deletion of 
CD151 increases RhoA activation (Johnson et al., 2009). CD151 
overexpression induces PKC-dependent activation of Rac and 
Cdc42, but not Rho, promoting cell adhesion (Shigeta et al., 2003). 
Also, resting levels of Rac activity are lowered in CD81-deficient 
dendritic cells (Quast et al., 2011). Our current findings thus provide 
a molecular explanation for the regulation of Rac by TEMs, indicat-
ing that CD81 regulates Rac1 dynamics and localization at the cell 
membrane during membrane protrusion and adhesion formation 
and establishing a mechanism through which this tetraspanin regu-
lates cell migration.
CD81-Rac complexes were most prominent at the cell leading 
edge. In this region, Rac promotes actin polymerization and the 
formation of dendritic actin branches through the activation of 
the actin-related proteins (Arp2/3) complex via Wiskott–Aldrich syn-
drome protein (WASP) family Verprolin-homologous protein (WAVE) 
proteins (Burridge and Wennerberg, 2004). CD81 and other tetras-
panins are also commonly used as protein markers of endosomes, 
lysosomes and exosomes (Simons and Raposo, 2009; Ostrowski 
et al., 2010). Therefore it is plausible that this interaction also occurs 
along the export/recycling route.
Most importantly, our data indicate that rather than being neces-
sary for Rac activation or translocation to the membrane, CD81 ab-
sence delays its inactivation. Compartmentalization of Rac at the 
plasma membrane by insertion into TEM might facilitate its binding 
to a Rho-GDP-dissociation inhibitor (Rho-GDI) protein that targets 
it for recycling or to a specific Rac-GTPase activating protein (Rac-GAP) 
or Rac effector. Compartmentalization of Rac at caveolin-rich mem-
brane domains is implicated in its internalization (del Pozo et al., 
2005) and degradation (Nethe et al., 2010). Rac interacts directly with 
caveolin, and depletion of caveolin results in Rac overexpression and 
hyperactivation (Nethe et al., 2010). Association of Rac with CD81 
does not appear to require caveolin, since caveolin was not detected 
among the proteins pulled down by CD81 C-terminal domain bait 
peptides. CD81 may thus provide an alternative mode of Rac com-
partmentalization at the membrane in cells with low or negligible 
caveolin expression. Importantly, the reduction in CD81 expression 
may slow Rac deactivation but does not lead to a constitutive activa-
tion of the GTPase, since a clear decay is observed at late time points 
of EGF stimulation. Therefore compartmentalization into TEM 
emerges as a novel regulatory mechanism of Rac activity turnover.
The increase in basal Rac activity in CD81-silenced cells or in 
cells pretreated with the permeable peptide correlates with higher 
protrusion rates and altered adhesion dynamics. Tetraspanins 
FIGURE 8: CD81 expression levels regulate cell migration 
(A) SUM159 cells were transfected with negative oligonucleotide or 
CD81 siRNA, together with GFP, GFP-CD81, or the GFP-tagged 
truncated C-terminal deletion form of CD81, and allowed to migrate 
onto 2 μg/ml fibronectin for 24 h. Charts depict individual tracks in a 
representative experiment. (B) Individual cell migration speeds are 
expressed in μm/h. Mean ± SEM from three independent 
experiments. **, p < 0.01; ***, p < 0.001 in one-way ANOVA. 
(C) SUM159 cells were transfected with GFP or GFP-CD81 and 
allowed to migrate onto 2 μg/ml fibronectin for 24 h. Individual cell 
migration speeds are expressed in μm/h. Mean ± SEM from three 
independent experiments. ***, p < 0.001 in Student’s t test. 
(D) SUM159 cells were preincubated for 1 h with 1 μM of the 
permeable peptides containing the sequence of the C-terminal 
cytoplasmic domain of CD81 or the scrambled version and allowed to 
migrate onto 2 μg/ml fibronectin for 24 h. Individual cell migration 
speeds are expressed in μm/h. Mean ± SEM from three independent 
experiments. **, p < 0.01 in Student’s t test.
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I.33.22 by R.Vilella (Hospital Clinic, Barcelona). Monoclonal anti-Rac1 
(clone 23A8) was purchased from Upstate (now Millipore, Billerica, 
MA); rabbit policlonal anti-Rac antibody was from Santa Cruz 
Biotechonology (Santa Cruz, CA), anti-vimentin clone VIM 3B4 
from Millipore (Billerica, MA); monoclonal antibody anti-paxillin, 
reference 03-6100, was from Zymed Laboratories (now Invitrogen, 
Carlsbad, CA), and clone 177 anti-paxillin was from BD Biosciences 
(Franklin Lanes, NJ).
Plasmids and reagents
The truncated CD81-ΔCyt-GFP was obtained using the specific 
primers: CTCGAGATGGGAGTGGAGGGCTGC (5′) and AAGCTTA-
CAGCACAGCACCATGCT (3′) by PCR onto a CD81 cDNA plasmid. 
The PCR product was first introduced into the TopoTA vector (Invit-
rogen) and then subcloned into pAcGFP-N1 or mRFP-N1 (Invitro-
gen). GFP-wild-type-Rac1, GFP-V12-Rac1 and Orange-paxillin have 
been previously described (del Pozo et al., 1999).
GST-Rac was provided by X.R. Bustelo (Centro de Investigación 
del Cancer, Salamanca, Spain); GST-PAK-Crib and C21-GST by 
J.G. Collard (The Netherlands Cancer Institute, Amsterdam, 
The Netherlands); and Enhanced Cyan Fluorescent Protein (ECFP)/
Ypet-based Raichu-Rac by Y. Wang (University of Illinois, Urbana–
Champaign, IL; Ouyang et al., 2008). pTRIP-CD81 (DsRed-CD81) and 
AqGFP-CD81 (Harris et al., 2008) were provided by J. McKeating 
(University of Birmingham, UK) and mEmerald-GFP-CD81 (GFP-
CD81) and mCherry-CD81 by M.W. Davidson (Florida State Univer-
sity, Tallahassee, FL). All CD81 plasmids had the fluorescent tag in the 
N-terminal region of the tetraspanin to avoid interference with 
C-terminal cytoplasmic region conformation or putative function. 
pEGFP-N1 was from Clontech (Mountain View, CA). EGF was pur-
chased from R&D (Minneapolis, MN) and used at 100 ng/ml at the 
indicated times. Fibronectin, GTP-γS and GDP were from Sigma-
Aldrich (St. Louis, MO).
Tetramethylrhodamine (TAMRA) N-terminal–labeled peptides 
with the sequences RRRRRRRCCGIRNSSVY (CD81) or RRRRRRRYS-
VNICRGCSS (Scrambled) were purchased from LifeTein (South 
Plainfield, NJ).
Pull-down assays
N-terminally biotinylated peptides containing a SGSG linker se-
quence connected to the cytoplasmic C-terminal domains of the 
proteins of interest were purchased from Ray Biotech, (Norcross, 
GA): CD81, biotin-SGSG-CCGIRNSSVY; CD9, biotin-SGSG-CCA-
IRRNREMV; CD151, biotin-SGSG-YRSLKLEHY; CD82, biotin-SGSG-
CRHVHSEDYSKVRKY; EWI-2, biotin-SGSG-CCFMKRLRKR; ICAM-1, 
biotin-SGSG-RQRKIKKYRLQQAQKGTPMKPTQATPP. Each peptide 
(30 nmol) was conjugated to 40 μl streptavidin-Sepharose (GE 
Healthcare, Uppsala, Sweden). Pull-down assays with T-lymphoblasts 
or HEK extracts were carried out as previously described (Sala-Valdes 
et al., 2006) and analyzed by Western blotting or mass spectrometry. 
Briefly, cells were washed once with ice-cold phosphate-buffered 
saline (PBS) and then lysed in 1% NP-40 in PBS containing protease 
and phosphatase inhibitors (Complete, PhosSTOP; Roche, Basel, 
Switzerland). Lysates were precleared for 2 h at 4ºC with streptavi-
din-Sepharose (GE Healthcare) and then incubated for 2 h at 4ºC 
with biotinylated peptides immobilized on streptavidin-Sepharose 
beads.
For preferential loading of Rac with GDP or GTP, cells were lysed 
in 5 mM EDTA-containing lysis buffer, and the lysates were incu-
bated with 50 nM of GTP-γS or GDP at 30ºC for 5 min before addi-
tion of 6 mM MgCl. Alternatively, cells treated, or not, with EGF 
were lysed in the presence of 2 mM MgCl before incubation with 
associate with integrins and partially colocalize with small focal 
adhesions in the cellular periphery (Berditchevski and Odintsova, 
1999). Our results suggest that CD81 may localize Rac to the lead-
ing edge anterior to nascent adhesions, thereby controlling Rac 
availability and favoring the initial steps in adhesion formation. 
CD81-deficient cells show a facilitated formation of adhesions that 
is similar to that observed in constitutively active Rac-expressing 
cells (del Pozo et al., 1999; Rottner et al., 1999; Webb et al., 2004; 
Choi et al., 2008). However, in contrast with cells expressing a con-
stitutive active form of Rac, the subsequent events of adhesion 
maturation are not grossly altered in CD81-silenced cells. Thus 
the combination of faster protrusion and spreading and the facilita-
tion of the initial steps of adhesion formation leads, at later time 
points, to an increased focal adhesion formation that slows cell mo-
tility. Moreover, adhesions in CD81 knocked-down cells are formed 
beyond the outer rim of the cell, and cytoskeletal polarity is lost, 
suggesting that CD81-dependent compartmentalization may also 
be crucial for the spatial regulation of Rac activity and cell polarity. 
Nevertheless, although cell polarity is perturbed in CD81-silenced 
cells, the persistence of migration in the absence of any directional 
cue was very low and no significant differences were observed be-
tween the experimental conditions (unpublished data).
Our results map the regulatory effect of CD81 to its C-terminal 
cytoplasmic region, which strongly suggests that the role of CD81 
in controlling cell migration is due to its interaction with Rac rather 
than its lateral association with other membrane receptors in the 
context of tetraspanin-enriched microdomains. Moreover, our data 
with cell-permeable peptides with the sequence of CD81 C-terminal 
domain suggest that these peptides may be an exciting tool to affect 
tetraspanin-dependent biological processes in vivo, offering a new, 
therapeutically valuable application of tetraspanin-targeted reagents 
for the treatment of malignancies or immune-related diseases.
MATERIALS AND METHODS
Cells
HUVEC were obtained and cultured as described elsewhere 
(Barreiro et al., 2008). SUM159 breast carcinoma cell line was cul-
tured in DMEM/F-12 (Life Technologies, Invitrogen, Carlsbad, CA), 
supplemented with 5% fetal bovine serum (FBS), 1% penicillin/
streptomycin, nonessential amino acids, 5 μg/ml insulin, and 1 μg/ml 
hydrocortisone. HEK and U2OS cells were cultured in DMEM (Lonza, 
Basel, Switzerland) or McCoy’s 5A medium (Life Techno logies), 
respectively, both supplemented with 10% FBS and 1% penicillin/
streptomycin. HMEC-1 microvascular endothelial cell line was grown 
in MCDB131 medium (Life Technologies) supplemented with 
20% FBS, 1% penicillin/streptomycin, 20 mM HEPES, 2.5 μg/ml 
fungizone, 10 ng/ml EGF, and 1 μg/ml hydrocortisone.
siRNA
Control siRNA was purchased from Dharmacon (Thermo Scientific, 
Lafayette, CO). Two different siRNAs for CD81 were purchased from 
Eurogentec (Seraign, Belgium): CD81b (CACCTTCTATGTAG-
GCATC) and CD81c (CACGTCGCCTTCAACTGTA). CD81c se-
quence corresponds to a nontranslated (3′UTR) region of CD81 
mRNA, which does not interfere with the expression of exogenous 
CD81. This sequence was used in rescue experiments.
Antibodies
VJ1/20 (anti-CD9), LIA1/1 (anti-CD151), VJ1/12 (anti-CD59), and 
HP2/9 (anti-CD44) monoclonal antibodies have been previously de-
scribed (Yáñez-Mó et al., 1998; Barreiro et al., 2005). Anti-CD81 5A6 
was kindly provided by S. Levy (Stanford University, CA), and 
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ously supplemented). For rescue experiments, the siRNA du-
plexes were electroporated together with 20 μg of GFP, GFP-
CD81, or CD81-ΔCyt-GFP.
Flow cytometry
CD81 membrane expression was routinely analyzed 48 or 72 h after 
transfection with siRNA duplexes by immunostaining with anti-
CD81 mAb in a FACScan Canto II cytofluorometer (BD Biosciences, 
Franklin Lanes, NJ), as previously described (Yáñez-Mó et al., 2008). 
Silencing of CD81 resulted in a reduction of mean fluorescence in-
tensity consistently greater than 50%. In rescue experiments, mem-
brane expression of CD81, stained with an APC-labeled goat anti-
mouse, was analyzed after gating GFP-positive cells.
Incorporation of cell-permeable, fluorescently TAMRA-labeled 
peptides was analyzed in trypsinized unstained cells by flow 
cytometry.
Fluorescence image cross-correlation analysis
U2OS cells were cotransfected with mCherry-CD81 (wild-type or 
cytoplasmic deletion mutant) and GFP-Rac1 (wild-type or V12 active 
mutant). TIRF images were acquired on an Olympus IX71 micro-
scope using a 60×/1.45 numerical aperture (NA) Plan-Apo oil objec-
tive and a Ludl controller (Ludl Electronic Products, Hawthorne, 
NY), and controlled by MetaMorph software (Molecular Devices, 
Downingtown, PA). GFP and mCherry were excited using a 488-nm 
line of an argon ion laser (Melles Griot, Albuquerque, NM) and a 
561-nm Cobolt Jive ion laser (Market Tech, Scotts Valley, CA), re-
spectively. For simultaneous dual-color imaging, a polychroic mirror 
(Z488/568 rpc) and dual-emission filter (Z488/568 nm; Chroma Tech-
nology, Bellows Falls, VT) were used. Image time series were ac-
quired with a charge-coupled device camera (Retiga Exi; QImaging, 
Surrey, Canada). Image processing and correlation analysis was 
performed in MATLAB 7.7.0 (MathWorks, Natick, MA). Images 
were corrected for background and photobleaching intensity ef-
fects. Cell regions (25 × 25 – 64 × 64 pixels) from both channels were 
selected for analysis. Single-channel auto- (a = b = 1 or 2) and cross-
correlation (a = 1; b = 2) functions were calculated following Wiseman 
et al. (2000):
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is the temporal lag time. Angular brackets …  denote spatial averag-
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ized by ia τ, the average intensity of the selected region at time t.
Activated Rac measurements
GTP-Rac loading was measured by pulling down GTP-loaded Rac 
using a GST-coupled PAK-CRIB construct immobilized on Sephar-
ose beads, as described elsewhere (Sander et al., 1999).
Alternatively, endothelial cells were cotransfected with ECFP/
Ypet Raichu-Rac and DsRed-CD81 and plated onto 2 μg/ml fi-
bronectin. Cells either untreated or stimulated with 100 ng/ml EGF 
were imaged using time-lapse confocal microscopy. FRET efficiency 
is presented as the yellow fluorescent protein (YFP)/cyan fluorescent 
protein (CFP) ratio after CFP stimulation, as previously described 
(Ouyang et al., 2008).
the Sepharose beads coated with the biotinylated peptides, PAK-
GST or C21-GST.
Mass spectrometry
Sepharose beads from the pull-down assays were directly resus-
pended in Laemmli buffer, applied onto a SDS–PAGE gel, and sub-
jected to the one-step in-gel trypsin digestion method (Bonzon-
Kulichenko et al., 2011). The resulting peptides were analyzed 
by liquid chromatography–tandem mass spectrometry (LC-MS/MS) 
using a Surveyor LC system coupled to an LTQ linear ion-trap mass 
spectrometer (Thermo Fisher, San Jose, CA), as previously described 
(Lopez-Ferrer et al., 2004; Jorge et al., 2009). The LTQ was operated 
in a data-dependent MS/MS mode using the 15 most intense pre-
cursors detected in a survey scan from 400 to 1600 m/z, as previ-
ously described (Lopez-Ferrer et al., 2004). Proteins were identified 
using the SEQUEST algorithm (Bioworks 3.2 package; Thermo 
Finnigan, Cambridge, MA); the raw MS/MS files were searched 
against the Human Swissprot database (Uniprot release 14.0, 19929 
sequence entries for human) supplemented with the sequence of 
porcine trypsin. SEQUEST results were validated using the probabil-
ity ratio method (Martinez-Bartolome et al., 2008), and false discov-
ery rates (FDR) were calculated by the refined method (Navarro and 
Vázquez, 2009). Peptide and scan counting was performed, assum-
ing as positive events those with a FDR equal to or lower than 5%.
Immunoprecipitation assays
Cells were plated onto 2 μg/ml of fibronectin and serum-starved for 
at least 6 h when indicated. EGF (100 ng/ml) was applied at the in-
dicated times before lysis in 0.5% Triton-X-100, 60 mM octylgluco-
side (Sigma-Aldrich) in Tris 10 mM (pH 8), 150 mM NaCl supple-
mented with protease and phosphatase inhibitors. Antibodies were 
precoupled to protein G–Sepharose (GE Healthcare), incubated 
with cell lysates, and washed several times with lysis buffer before 
being loaded onto an SDS–PAGE gel.
Fluorescence microscopy
For immunofluorescence, cells were fixed with 4% paraformalde-
hyde (Electron Microscopy Sciences, Hatfield, PA), permeabilized 
with 0.5% Triton X-100 (5 min), and stained with corresponding pri-
mary antibodies followed by species-matching secondary antibod-
ies (Invitrogen). Samples were analyzed in a Leica TCS-SP5 confocal 
laser-scanning unit equipped with Ar and He/Ne laser beams and 
attached to a Leica DMIRBE inverted epifluorescence microscope 
(Leica Microsystems, Heidelberg, Germany); in a TIRF microscope 
(Leica Microsystems, on a Leica DMI 6000B) using ∼100-nm depth 
penetration; or a wide-field fluorescence Leica DMIRE2 microscope 
coupled to a monochromator (Polychrome IV; Till Photonics, Munich, 
Germany) and a CCD camera (CoolSNAP HQ; Photometrics, Tuc-
son, AZ). For time-lapse fluorescence microscopy, cells were main-
tained at 37ºC in 5% CO2.
For quantification of focal adhesions, subconfluent HUVEC cul-
tures were plated onto 2 μg/ml fibronectin 72 h after transfection, 
fixed, permeabilized, and stained for paxillin. The area of focal ad-
hesions was selected and measured by Image J using a threshold-
ing method.
Transfection experiments
For DNA or siRNA transfection, cells were electroporated with 
2 μM of either negative siRNA or CD81 siRNA duplexes or 20 μg 
of plasmid DNA, in a Gene Pulser II device (Bio-Rad, Hercules, 
CA). Conditions used were 200 V, 0.975 × 10−9 Faradays, in 
200 μl of standard medium (5 μl of 1.5 M NaCl had been previ-
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Protrusion rate and adhesion turnover measurements
SUM159 cells were either transfected with GFP or CD81-GFP, cotrans-
fected with control or CD81 siRNA and GFP, or transfected with GFP 
and incubated 2 h with 1 μM permeable CD81 or scrambled 
peptides. Cells were then trypsinized, washed, and plated onto 35-mm 
dishes (MatTek) coated with 10 μg/ml of fibronectin. Images were ac-
quired for 10 min with 1 frame every 5 s using a Leica AM TIRF MC 
mounted on a Leica DMI6000B microscope fitted with a 100×/1.46 NA 
oil-immersion objective with 1× magnification and ∼90-nm penetration 
depth. The protrusion rate was measured with Image J’s Multiple 
Kymograph plug-in, as described elsewhere (Choi et al., 2008).
For the study of focal adhesion turnover, cells cotransfected with 
Orange-paxillin, together with control or CD81siRNA and GFP, GFP-
CD81, or CD81-ΔCyt-GFP, were allowed to spread, and adhesion 
assembly and disassembly rates were analyzed with Image J, as pre-
viously described (Webb et al., 2004; Choi et al., 2008).
Spreading assays on micropatterned substrates
Micropatterned slides were purchased from CYTOO (Grenoble, 
France). Cells were trypsinized and replated onto micropatterned 
slides (CYTOO Starter), according to the manufacturer’s instructions. 
Cells were allowed to attach and spread for 3 h and were then fixed 
with paraformaldehyde, permeabilized, and stained for paxillin or F-
actin. Images were acquired using wide-field fluorescence microscopy 
and analyzed with the Image J Reference-cell macro. Briefly, images 
were cropped following the micropatterned image and micropatterns 
containing multiple cells were discarded by nuclei counting. Average 
projections of the label image of several individual cells (paxillin or F-
actin) are presented in a pseudocolor intensity-scale image.
Migration experiments
SUM159 cells were plated on fibronectin (2 μg/ml) 2 d after transfec-
tion and serum-starved for 12 h. Alternatively, SUM159 were plated 
on fibronectin (2 μg/ml) and incubated for 1 h with 1 μM permeable 
CD81 or scrambled peptides. Images were acquired at 10-min 
intervals for 24 h in a Nikon Eclipse Ti-E video microscope (Tokyo, 
Japan). Tracking of transfected cells was performed with Image J 
and MetaMorph software.
Statistical analysis
Statistical significance was calculated using Student’s t test or one-
way analysis of variance (ANOVA), and significant differences were 
labeled as: *, p < 0.05; **, p < 0.01; and ***, p < 0.001.
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